Pembrolizumab-associated ocular myasthenia gravis

Clin Exp Ophthalmol. 2019 Aug;47(6):796-798. doi: 10.1111/ceo.13499. Epub 2019 Apr 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Electromyography
  • Humans
  • Male
  • Melanoma / drug therapy
  • Myasthenia Gravis / chemically induced*
  • Myasthenia Gravis / diagnosis
  • Myasthenia Gravis / physiopathology
  • Oculomotor Muscles / drug effects
  • Oculomotor Muscles / physiopathology
  • Skin Neoplasms / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab